Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Canada
  4. Toronto Stock Exchange
  5. Opsens Inc.
  6. News
  7. Summary
    OPS   CA6838231083

OPSENS INC.

(OPS)
  Report
Delayed Quote. Delayed Toronto Stock Exchange - 01/28 03:59:46 pm
1.98 CAD   +1.02%
01/28OPSENS : Corrected and Refiled Financial Statements 2021
PU
01/28OPSENS : Form 52-109f1r
PU
01/24Opsens named to 2022 otcqx best 50
AQ
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Opsens : Certification CEO

11/24/2021 | 11:20am EST

FORM 52-109F1

CERTIFICATION OF ANNUAL FILINGS

FULL CERTIFICATE

I, Louis Laflamme, President and Chief Executive Officer of Opsens Inc., certify the following:

  1. Review: I have reviewed the AIF, if any, annual financial statements and annual MD&A, including, for greater certainty, all documents and information that are incorporated by reference in the AIF (together, the "annual filings") of Opsens Inc. (the "issuer") for the financial year ended August 31, 2021.
  2. No misrepresentations: Based on my knowledge, having exercised reasonable diligence, the annual filings do not contain any untrue statement of a material fact or omit to state a material fact required to be stated or that is necessary to make a statement not misleading in light of the circumstances under which it was made, for the period covered by the annual filings.
  3. Fair presentation: Based on my knowledge, having exercised reasonable diligence, the annual financial statements together with the other financial information included in the annual filings fairly present in all material respects the financial condition, financial performance and cash flows of the issuer, as of the date of and for the periods presented in the annual filings.
  4. Responsibility: The issuer's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (DC&P) and internal control over financial reporting (ICFR), as those terms are defined in Regulation 52-109respecting Certification of Disclosure in Issuers' Annual and Interim Filings (c. V-1.1, r. 27) , for the issuer.
  5. Design: Subject to the limitations, if any, described in paragraphs 5.2 and 5.3, the issuer's other certifying officer(s) and I have, as at the financial year end
    1. designed DC&P, or caused it to be designed under our supervision, to provide reasonable assurance that
      1. material information relating to the issuer is made known to us by others, particularly during the period in which the annual filings are being prepared; and
      2. information required to be disclosed by the issuer in its annual filings, interim filings or other reports filed or submitted by it under securities legislation is recorded, processed, summarized and reported within the time periods specified in securities legislation; and
    2. designed ICFR, or caused it to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with the issuer's GAAP.
  1. Control framework: The control framework the issuer's other certifying officer(s) and I used to design the issuer's ICFR is Committee of Sponsoring Organizations of the Treadway Commission (COSO).
  2. N/A
  3. N/A

6. Evaluation: The issuer's other certifying officer(s) and I have

  1. evaluated, or caused to be evaluated under our supervision, the effectiveness of the issuer's DC&P at the financial year end and the issuer has disclosed in its annual MD&A our conclusions about the effectiveness of DC&P at the financial year end based on that evaluation; and
  2. evaluated, or caused to be evaluated under our supervision, the effectiveness of the issuer's ICFR at the financial year end and the issuer has disclosed in its annual MD&A
  1. our conclusions about the effectiveness of ICFR at the financial year end based on that evaluation.

(ii)N/A

  1. Reporting changes in ICFR: The issuer has disclosed in its annual MD&A any change in the issuer's ICFR that occurred during the period beginning on June 1, 2021 and ended on August 31, 2021 that has materially affected, or is reasonably likely to materially affect, the issuer's ICFR.
  2. Reporting to the issuer's auditors and board of directors or audit committee: The issuer's other certifying officer(s) and I have disclosed, based on our most recent evaluation of ICFR, to the issuer's auditors, and the board of directors or the audit committee of the board of directors any fraud that involves management or other employees who have a significant role in the issuer's ICFR.

Date: November 23, 2021

  1. Louis Laflamme______
    Louis Laflamme
    President and Chief Executive Officer Opsens Inc.

Disclaimer

OPSENS Inc. published this content on 24 November 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 24 November 2021 16:19:07 UTC.


ę Publicnow 2021
All news about OPSENS INC.
01/28OPSENS : Corrected and Refiled Financial Statements 2021
PU
01/28OPSENS : Form 52-109f1r
PU
01/24Opsens named to 2022 otcqx best 50
AQ
01/13OPSENS : 52-109 F2 CEO Certification
PU
01/13OPSENS : 52-109 F2 CFO Certification
PU
01/13Opsens Inc. Reports Earnings Results for the First Quarter Ended November 30, 2021
CI
01/13OpSens Reports Q1 Loss of $0.02 Per Diluted Share, as Q1 Revenue Misses Forecast
MT
01/13OPSENS BRIEF : Q1 Revs $8.096 Million Vs Forecast 8.53 Million and Last Year 8.34 Million
MT
01/13OPSENS BRIEF : Q1 EPS Basic and Diluted ($0.02) Vs Forecast EPS Normalized ($0.01) As Per ..
MT
01/13OpSens Announces FIRST Quarter fiscal 2022 Financial Results
AQ
More news
Analyst Recommendations on OPSENS INC.
More recommendations
Financials
Sales 2022 38,6 M 30,2 M 30,2 M
Net income 2022 -5,70 M -4,46 M -4,46 M
Net Debt 2022 - - -
P/E ratio 2022 -49,5x
Yield 2022 -
Capitalization 214 M 168 M 168 M
Capi. / Sales 2022 5,55x
Capi. / Sales 2023 3,40x
Nbr of Employees 163
Free-Float 95,0%
Chart OPSENS INC.
Duration : Period :
Opsens Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends OPSENS INC.
Short TermMid-TermLong Term
TrendsBearishBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 5
Last Close Price 1,98 CAD
Average target price 4,29 CAD
Spread / Average Target 117%
EPS Revisions
Managers and Directors
Louis Laflamme President, Chief Executive Officer & Director
Robin Villeneuve Chief Financial Officer & Secretary
Alan W. Milinazzo Executive Chairman
Jean Lavigueur Independent Director
Denis L. Harrington Independent Director
Sector and Competitors
1st jan.Capi. (M$)
OPSENS INC.-36.13%168
THERMO FISHER SCIENTIFIC-17.01%218 200
DANAHER CORPORATION-14.56%192 914
INTUITIVE SURGICAL, INC.-24.36%93 871
SIEMENS HEALTHINEERS AG-11.64%72 393
EDWARDS LIFESCIENCES CORPORATION-19.05%63 657